Angiosonics to market Acolysis outside US
This article was originally published in Clinica
Executive Summary
Angiosonics will launch its Acolysis system for dissolving blood clots in non-US markets this summer. The system is a catheter-based device which uses high-frequency ultrasound to turn blood clots into blood, and restore circulation in blocked arteries.